During the past decade, Kyushu University Hospital Respiratory Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kyushu University Hospital Respiratory Medicine" are "Non Squamous Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Kyushu University Hospital Respiratory Medicine" in a lesser frequency.

Most popular intervention types in "Kyushu University Hospital Respiratory Medicine" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator (erlotinib)" (1 trials), "Dacomitinib (PF-00299804)" (1 trials), "Placebo PF00299804" (1 trials), "Placebo erlotinib" (1 trials) and "treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kyushu University Hospital Respiratory Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kyushu University Hospital Respiratory Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kyushu University Hospital Respiratory Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kyushu University Hospital Respiratory Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".